Mark Tepper, President and CSO at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 2,000 shares at $3.05 ($6K) on 2014-11-25, disclosed to the SEC on 2014-11-26.
Open-market purchase of $6k CRBP by President and CSO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| CYTR | SELL | 2007-05-01 | $308K | — | Filing → |